DMPI - DelMar Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 522.59M
Enterprise Value 312.64M
Trailing P/E N/A
Forward P/E 1-3.96
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)6.56
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2017
Most Recent Quarter (mrq)Dec 31, 2017


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-82.99%
Return on Equity (ttm)-162.35%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-10.72M
Diluted EPS (ttm)-0.68
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)11.02M
Total Cash Per Share (mrq)0.5
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)5.47
Book Value Per Share (mrq)0.16

Cash Flow Statement

Operating Cash Flow (ttm)-9.46M
Levered Free Cash Flow (ttm)-5.58M

Trading Information

Stock Price History

Beta 1.94
52-Week Change 3-74.67%
S&P500 52-Week Change 315.95%
52 Week High 35.20
52 Week Low 30.78
50-Day Moving Average 31.21
200-Day Moving Average 31.07

Share Statistics

Avg Vol (3 month) 3941.34k
Avg Vol (10 day) 3145.4k
Shares Outstanding 521.93M
Float 18.84M
% Held by Insiders 17.67%
% Held by Institutions 115.08%
Shares Short 31.25M
Short Ratio 32.21
Short % of Float 36.27%
Shares Short (prior month) 31.06M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A